Null Mutation of the Lmo4 Gene or a Combined Null Mutation of the Lmo1/Lmo3 Genes Causes Perinatal Lethality, and Lmo4 Controls Neural Tube Development in Mice
- 1 March 2004
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 24 (5) , 2063-2073
- https://doi.org/10.1128/mcb.24.5.2063-2073.2004
Abstract
The LIM-only family of proteins comprises four members; two of these (LMO1 and LMO2) are involved in human T-cell leukemia via chromosomal translocations, and LMO2 is a master regulator of hematopoiesis. We have carried out gene targeting of the other members of the LIM-only family, viz., genes Lmo1, Lmo3 and Lmo4, to investigate their role in mouse development. None of these genes has an obligatory role in lymphopoiesis. In addition, while null mutations of Lmo1 or Lmo3 have no discernible phenotype, null mutation of Lmo4 alone causes perinatal lethality due to a severe neural tube defect which occurs in the form of anencephaly or exencephaly. Since the Lmo1 and Lmo3 gene sequences are highly related and have partly overlapping expression domains, we assessed the effect of compound Lmo1/Lmo3 null mutations. Although no anatomical defects were apparent in compound null pups, these animals also die within 24 h of birth, suggesting that a compensation between the related Lmo1 and 3 proteins can occur during embryogenesis to negate the individual loss of these genes. Our results complete the gene targeting of the LIM-only family in mice and suggest that all four members of this family are important in regulators of distinct developmental pathways.Keywords
This publication has 61 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- Characterization of a Cerebellar Granule Cell-Specific Gene Encoding the γ-Aminobutyric Acid Type A Receptor α6 SubunitJournal of Neurochemistry, 2002
- The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug targetOncogene, 2002
- The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid developmentCell, 1994
- The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse developmentJournal of Molecular Biology, 1992
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992
- Translocations, master genes, and differences between the origins of acute and chronic leukemiasCell, 1991
- Cell lineages in peripheral nervous system ontogeny: Medium-induced modulation of neuronal phenotypic expression in neural crest cell culturesDevelopmental Biology, 1987
- Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoterGene, 1987
- Diversity and rearrangement of the human T cell rearranging γ genes: Nine germ-line variable genes belonging to two subgroupsCell, 1986